Glycogen storage disease type III: Difference between revisions
No edit summary |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For the main page on glycogen storage disease, please click [[Glycogen storage disease|here]]'''<br> | |||
'''For patient information click [[Glycogen storage disease type III (patient information)|here]]''' | |||
{{Glycogen storage disease type III}} | {{Glycogen storage disease type III}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Anmol}} | ||
{{ | |||
{{ | {{SK}} Glycogen storage disease type 3; GSD type 3; GSD 3; Cori disease; Forbes disease; limit dextrinosis; glycogenosis type 3; amylo-1, 6-glucosidase deficiency; debrancher enzyme deficiency; glycogen debranching enzyme deficiency; AGL deficiency; GDE deficiency; 4-alpha-glucanotransferase enzyme deficiency. | ||
==Overview== | ==[[Glycogen storage disease type III overview|Overview]]== | ||
==Historical Perspective== | ==[[Glycogen storage disease type III historical perspective|Historical Perspective]]== | ||
==Classification== | ==[[Glycogen storage disease type III classification|Classification]]== | ||
==Pathophysiology== | ==[[Glycogen storage disease type III pathophysiology|Pathophysiology]]== | ||
==Causes== | ==[[Glycogen storage disease type III causes|Causes]]== | ||
== | ==[[Glycogen storage disease type III differential diagnosis|Differentiating Glycogen Storage Disease Type III from other Diseases]]== | ||
==Epidemiology and Demographics== | ==[[Glycogen storage disease type III epidemiology and demographics|Epidemiology and Demographics]]== | ||
==Risk Factors== | ==[[Glycogen storage disease type III risk factors|Risk Factors]]== | ||
==Screening== | ==[[Glycogen storage disease type III screening|Screening]]== | ||
==Natural History, Complications | ==[[Glycogen storage disease type III natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Glycogen storage disease type III diagnostic study of choice|Diagnostic study of choice]] | [[Glycogen storage disease type III history and symptoms|History and Symptoms]] | [[Glycogen storage disease type III physical examination|Physical Examination]] | [[Glycogen storage disease type III electrocardiogram|Electrocardiogram]] | [[Glycogen storage disease type III laboratory findings|Laboratory Findings]] | [[Glycogen storage disease type III x ray|X-Ray Findings]] | [[Glycogen storage disease type III echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Glycogen storage disease type III CT scan|CT-Scan Findings]] | [[Glycogen storage disease type III MRI|MRI Findings]] | [[Glycogen storage disease type III other diagnostic studies|Other Diagnostic Studies]] | [[Glycogen storage disease type III other imaging findings|Other Imaging Findings]] | |||
==Treatment== | ==Treatment== | ||
[[Glycogen storage disease type III medical therapy|Medical Therapy]] | [[Glycogen storage disease type III surgery|Surgery]] | [[Glycogen storage disease type III primary prevention|Primary Prevention]] | [[Glycogen storage disease type III secondary prevention|Secondary Prevention]] | [[Glycogen storage disease type III cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type III future or investigational therapies|Future or Investigational Therapies]] | |||
==Related chapters== | ==Related chapters== | ||
| Line 67: | Line 42: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[pl:Choroba Coriego]] | [[pl:Choroba Coriego]] | ||
| Line 78: | Line 48: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Endocrinology]] | |||
[[Category:Hepatology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Metabolic disorders]] | |||
Latest revision as of 18:04, 31 January 2018
For the main page on glycogen storage disease, please click here
For patient information click here
|
Glycogen storage disease type III Microchapters |
|
Differentiating Glycogen storage disease type III from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type III On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type III |
|
Risk calculators and risk factors for Glycogen storage disease type III |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Synonyms and keywords: Glycogen storage disease type 3; GSD type 3; GSD 3; Cori disease; Forbes disease; limit dextrinosis; glycogenosis type 3; amylo-1, 6-glucosidase deficiency; debrancher enzyme deficiency; glycogen debranching enzyme deficiency; AGL deficiency; GDE deficiency; 4-alpha-glucanotransferase enzyme deficiency.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glycogen Storage Disease Type III from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies